These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Vincristine-induced neuropathy in rat: electrophysiological and histological study. Ja'afer FM; Hamdan FB; Mohammed FH Exp Brain Res; 2006 Aug; 173(2):334-45. PubMed ID: 16736180 [TBL] [Abstract][Full Text] [Related]
8. Comparison of subchronic neurotoxicity of 2-hydroxyethyl acrylate and acrylamide in rats. Moser VC; Anthony DC; Sette WF; MacPhail RC Fundam Appl Toxicol; 1992 Apr; 18(3):343-52. PubMed ID: 1597260 [TBL] [Abstract][Full Text] [Related]
9. Relative refractory period as a measure of peripheral nerve neurotoxicity. Anderson RJ Toxicol Appl Pharmacol; 1983 Dec; 71(3):391-7. PubMed ID: 6318389 [TBL] [Abstract][Full Text] [Related]
10. An ACTH-(4-9) analogue, Org 2766, improves recovery from acrylamide neuropathy in rats. Sporel-Ozakat RE; Edwards PM; Van der Hoop RG; Gispen WH Eur J Pharmacol; 1990 Sep; 186(2-3):181-7. PubMed ID: 1963145 [TBL] [Abstract][Full Text] [Related]
11. Mitochondrial schwannopathy and peripheral myelinopathy in a rabbit model of dideoxycytidine neurotoxicity. Anderson TD; Davidovich A; Feldman D; Sprinkle TJ; Arezzo J; Brosnan C; Calderon RO; Fossom LH; DeVries JT; DeVries GH Lab Invest; 1994 May; 70(5):724-39. PubMed ID: 7515130 [TBL] [Abstract][Full Text] [Related]
12. Metabolic interaction and neurological effect of combined exposure to acrylamide and ethanol. Stetkiewicz J; Wrońska-Nofer T; Klimczak J; Stetkiewicz I Pol J Occup Med; 1988; 1(2):127-36. PubMed ID: 2979596 [No Abstract] [Full Text] [Related]
13. A review of acrylamide neurotoxicity. Part II. Experimental animal neurotoxicity and pathologic mechanisms. Spencer PS; Schaumburg HH Can J Neurol Sci; 1974 Aug; 1(3):152-69. PubMed ID: 4609589 [No Abstract] [Full Text] [Related]
14. Studies on drug-induced neuropathies. III. Motor nerve deficit in cats with experimental acrylamide neuropathy. Lowndes HE; Baker T Eur J Pharmacol; 1976 Jan; 35(1):177-84. PubMed ID: 1253819 [TBL] [Abstract][Full Text] [Related]
15. Acrylamide autonomic neuropathy in the cat. Part 1. Neurophysiological and histological studies. Post EJ; McLeod JG J Neurol Sci; 1977 Sep; 33(3):353-74. PubMed ID: 915523 [TBL] [Abstract][Full Text] [Related]
16. Studies of the primate somatosensory system in experimental acrylamide intoxication. Schaumburg HH; Spencer PS; Arezzo JC Neurotoxicology; 1985; 6(4):3-6. PubMed ID: 4088541 [TBL] [Abstract][Full Text] [Related]
17. Does pyruvate prevent acrylamide neurotoxicity? Implications for disease pathogenesis. Sterman AB; Panasci DJ; Persons W Exp Neurol; 1983 Oct; 82(1):148-58. PubMed ID: 6628605 [TBL] [Abstract][Full Text] [Related]
18. Acrylamide neuropathy: changes in the composition of proteins of fast axonal transport resemble those observed in regenerating axons. Bisby MA; Redshaw JD J Neurochem; 1987 Mar; 48(3):924-8. PubMed ID: 2433402 [TBL] [Abstract][Full Text] [Related]
19. Preferential block of small myelinated sensory and motor fibers by lidocaine: in vivo electrophysiology in the rat sciatic nerve. Gokin AP; Philip B; Strichartz GR Anesthesiology; 2001 Dec; 95(6):1441-54. PubMed ID: 11748404 [TBL] [Abstract][Full Text] [Related]
20. Prolonged exposure to trimethylphosphate induces sensory motor neuropathy in the dog. Schaeppi U; Krinke G; Kobel W Neurobehav Toxicol Teratol; 1984; 6(1):39-50. PubMed ID: 6325969 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]